Ardana Bioscience Ltd.'s Novel Testosterone Cream Remains On Track For Q4 2007 Launch Following Pre-IND Meeting With US FDA

Ardana plc (LSE:ARA) today reports on a pre-Investigational New Drug (IND) meeting with the US Food and Drug Administration (FDA) to discuss the development of its novel cream for testosterone replacement in male hypogonadism

MORE ON THIS TOPIC